Multivariate symptom analysis related to response to lorazepam treatment
Current Medical Research and Opinion
|January 1, 1979
Summary
This study investigated lorazepam effectiveness in psychiatric patients. Results show that anxiety, phobic, and psychosomatic symptoms strongly predict positive responses to lorazepam treatment.
Area of Science:
- Psychiatry
- Clinical Psychology
- Pharmacology
Background:
- Inter-trial variability exists in reported patient benefits from the anxiolytic agent lorazepam.
- Many patients in the study had treatment-resistant, moderate-to-severe symptoms and comorbid diagnoses.
Purpose of the Study:
- To explain the significant inter-trial differences in lorazepam's reported efficacy.
- To identify specific symptom clusters correlating with therapeutic response to lorazepam.
Main Methods:
- Statistical analysis of psychiatric symptom questionnaire scores from 69 out-patients before and after lorazepam treatment.
- Multivariate analysis examined the relationship between 6 symptom clusters and therapeutic response.
Main Results:
- Forty out of 69 patients showed a favorable response to lorazepam.
- High correlations were found between response to lorazepam and anxiety, phobic, and psychosomatic symptom scores.
- Depression scores showed borderline significance; hysteria and obsessionality scores showed poor correlation with response.
Conclusions:
- Patient diagnostic composition may explain inter-trial differences in lorazepam efficacy.
- Lorazepam may be particularly effective for patients with prominent anxiety, phobic, and psychosomatic symptoms.
- Further research into patient heterogeneity is warranted to optimize anxiolytic treatment selection.
More Related Videos
Related Concept Videos
Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...


